VDF FutureCeuticals v. Applied Food Sciences — Dismissed With Prejudice After 366 Days
VDF FutureCeuticals filed suit against Applied Food Sciences in the Colorado District Court asserting six patents covering low-mycotoxin coffee cherry ingredients and processing methods. The parties jointly stipulated to dismiss all claims with prejudice within exactly one year of filing, with each side absorbing its own legal costs.
Six-patent coffee cherry ingredient dispute resolved in exactly one year
On 6 February 2023, VDF FutureCeuticals, Inc. — a functional ingredient company and holder of a portfolio of patents covering coffee cherry-derived products — filed an infringement action against Applied Food Sciences, Inc. in the United States District Court for the District of Colorado (Case No. 1:23-cv-00347). The complaint asserted six US patents spanning low-mycotoxin coffee cherry compositions and the processing methods used to produce them.
The case closed on 7 February 2024 — exactly 366 days after filing — when both parties jointly filed a stipulation of dismissal under Federal Rule of Civil Procedure 41(a)(1). All claims were dismissed with prejudice, meaning VDF FutureCeuticals is permanently barred from bringing the same patent claims against Applied Food Sciences in any future action. Crucially, the stipulation specified that each party would bear its own attorneys’ fees, costs, and expenses, suggesting a negotiated resolution rather than a concession by either side.
Resolution within one year of a six-patent infringement action is relatively swift and is consistent with a private settlement reached before substantive motion practice or claim construction proceedings. The absence of any publicly recorded damages award, licensing disclosure, or consent judgment means the commercial terms — if any were agreed — remain entirely confidential. What drove the early resolution and whether a licensing arrangement underlies the dismissal cannot be determined from the public docket alone.
Filing to dismissal in 366 days
366 days — resolved within one calendar year, faster than many multi-patent infringement cases
Stipulated dismissal with prejudice — what it means for both parties
Rule 41(a)(1) stipulated dismissal explained
A dismissal under FRCP 41(a)(1) requires the agreement of all parties and takes effect without a court order once filed. It is a common procedural vehicle for ending litigation after a private resolution is reached. Because no court order is required, the mechanism leaves the underlying terms of any agreement entirely off the public record — making it impossible to infer whether money changed hands or a licence was granted.
FRCP 41(a)(1) — by stipulationWith prejudice bars VDF from refiling these claims
A dismissal with prejudice operates as a final adjudication on the merits for preclusion purposes. VDF FutureCeuticals cannot reinstate or refile the same infringement claims against Applied Food Sciences on the same six patents for the same accused products. This is a meaningful concession by the plaintiff and typically signals that the dispute has been commercially resolved — though the public record does not confirm the specific terms.
Permanent bar on refilingEach party bears its own costs — no prevailing party declared
The stipulation expressly allocates attorneys’ fees, costs, and expenses to the party that incurred them. This ‘own costs’ structure is characteristic of negotiated resolutions and avoids any court determination of a prevailing party. It also forecloses a subsequent fee motion under 35 U.S.C. § 285 (exceptional case), which defendants sometimes pursue after a voluntary dismissal with prejudice.
No § 285 fee exposureSix-patent assertion signals a broad IP perimeter
Asserting six patents in a single complaint — covering both compositions (low-mycotoxin coffee cherry products) and methods — is consistent with a plaintiff seeking to maximise claim coverage and foreclose design-arounds. The breadth of the assertion may itself have accelerated resolution by raising the cost and risk of litigation for the defendant, or alternatively by creating grounds for a cross-licence or broader commercial arrangement.
Composition + method claimsFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | VDF FutureCeuticals, Inc. | Company | Functional ingredient company — holder of six US coffee cherry patentsSearch in Eureka ↗ |
| Defendant | Applied Food Sciences, Inc. | Company | Applied Food Sciences, Inc. — specialty ingredient supplier, coffee-derived product developerSearch in Eureka ↗ |
| Plaintiff counsel | Alexander Colin Wexler | Attorney | Counsel for VDF FutureCeuticals, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Benjamin Will Chertok | Attorney | Counsel for VDF FutureCeuticals, Inc.Search in Eureka ↗ |
| Plaintiff counsel | J. Mark Smith | Attorney | Counsel for VDF FutureCeuticals, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Paul J. Sauerteig | Attorney | Counsel for VDF FutureCeuticals, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Robert D. Leighton | Attorney | Counsel for VDF FutureCeuticals, Inc.Search in Eureka ↗ |
| Defendant counsel | David G. Henry , Sr. | Attorney | Counsel for Applied Food Sciences, Inc.Search in Eureka ↗ |
| Defendant counsel | Jordan Christine Strauss | Attorney | Counsel for Applied Food Sciences, Inc.Search in Eureka ↗ |
| Presiding judge | Judge / | Chief Judge | Colorado District Court — Chief JudgeSearch in Eureka ↗ |
Stipulation of dismissal — official text
The stipulation’s language — ‘all claims asserted therein be dismissed with prejudice, with each party bearing its own attorneys’ fees, costs, and expenses’ — is a textbook negotiated exit. The with-prejudice designation protects Applied Food Sciences from future suit on the same patents, while the own-costs allocation avoids any public concession of fault or infringement. Neither admission of liability nor licensing terms appear on the face of the document, leaving the commercial resolution, if any, entirely private.
US7807205B2 and five further patents — coffee cherry composition and processing IP
The six asserted patents — US7807205B2, US7815959B2, US7754263B2, US8603564B2, US8597710B2, and US8603563B2 — originate from application numbers suggesting two distinct priority clusters (the 10/552xxx series and the 12/xxx–13/xxx series), consistent with a portfolio built through continuation and divisional filings from foundational applications. The patents cover low-mycotoxin coffee cherry compositions and the proprietary methods used to produce them, addressing a commercially significant safety and quality parameter in coffee by-product ingredients.
Coffee cherry — the fruit surrounding the coffee bean, historically discarded — has attracted growing commercial interest as a source of antioxidants, polyphenols, and caffeine for functional food and supplement applications. VDF FutureCeuticals is a recognised player in this ingredient category. A portfolio covering both the composition (specifying mycotoxin thresholds) and the methods of production creates a strong IP perimeter that is difficult for competitors to design around without either licensing or fundamentally altering their sourcing and processing approach.
Should you run an FTO against VDF FutureCeuticals’ coffee cherry patent family?
Any R&D team or product formulator working with coffee cherry extract, cascara, coffee fruit powder, or related coffee by-product ingredients should treat this six-patent family as a priority FTO target. The patents cover both what the product is (low-mycotoxin composition) and how it is made (processing methods) — meaning a product clearance alone is insufficient if your manufacturing process falls within the method claims.
PatSnap Eureka’s FTO Search Agent can map all six patent numbers against your product specifications and process parameters, flag active claims, and surface any continuations or divisionals filed from the same priority chains. Claim-level monitoring ensures you are alerted if VDF files additional patents from these families — a material risk given the multi-application structure of this portfolio.
Run a freedom-to-operate analysis on US7807205B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent cases in functional ingredients and coffee technology
PatSnap Eureka tracks related litigation across truck body equipment, vehicle accessories, and comparable infringement actions in the Georgia district system.
What this case signals for the functional ingredient IP landscape
A swift, confidential resolution of a six-patent coffee cherry dispute highlights how aggressively IP is being enforced in the specialty ingredient space.
Coffee cherry IP is actively enforced — competitors face real litigation risk
VDF FutureCeuticals’ willingness to assert six patents simultaneously signals a portfolio built for enforcement, not just defensive purposes. Companies commercialising coffee cherry extracts, cascara, or related by-product ingredients should treat FutureCeuticals’ patent family as a live risk — not background art.
Own-costs dismissals often mask confidential licences — monitor product launches
When a plaintiff with strong patent coverage dismisses with prejudice on own-costs terms, a private licensing or commercial arrangement is a plausible explanation. Applied Food Sciences’ post-case product activity in the coffee cherry category may indicate whether a licence was granted or the company pivoted its formulation approach.
VDF v Applied — key questions answered
VDF FutureCeuticals filed a patent infringement action against Applied Food Sciences in the District of Colorado on 6 February 2023, asserting six patents covering low-mycotoxin coffee cherry products and methods. The case was dismissed with prejudice by joint stipulation on 7 February 2024, with each party bearing its own costs. No damages or licensing terms were publicly disclosed.
Six US patents were asserted: US7807205B2, US7815959B2, US7754263B2, US8603564B2, US8597710B2, and US8603563B2. The patents cover low-mycotoxin coffee cherry compositions and the processing methods used to produce them, spanning two distinct priority application clusters.
Dismissal with prejudice means VDF FutureCeuticals is permanently barred from refiling the same patent infringement claims against Applied Food Sciences on the six asserted patents for the same accused products. Applied Food Sciences receives finality on those specific claims. However, VDF retains its underlying patent rights and could pursue different defendants or different products.
The public record does not disclose any damages award, royalty payment, or licensing arrangement. The stipulation of dismissal states only that each party bears its own attorneys’ fees, costs, and expenses. Any commercial terms agreed between the parties would be confidential and are not reflected in the court docket.
The case involved low-mycotoxin coffee cherry products and methods for producing coffee cherry-derived ingredients. Coffee cherry — the fruit surrounding the coffee bean — is used in functional food, beverage, and supplement applications. The patent claims address both the composition specifications (including mycotoxin control) and the manufacturing processes.
PatSnap Eureka searches patents and litigation data to answer instantly.